Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-5 av 5

2022
1 Imbery, John Franklin; Heinzelbecker, Julia; Jebsen, Jenny Karoline; McGowan, Marc Kevin; Myklebust, Camilla Victoria; Bottini, Nunzio; Stanford, Stephanie M.; Skånland, Sigrid S; Tveita, Anders Aune; Tjønnfjord, Geir Erland; Munthe, Ludvig Andre; Szodoray, Peter; Nakken, Britt.
T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation. British Journal of Haematology 2022 ;Volum 198.(3) s. 556-573
OUS UiO Untitled
 
2 Kaźmierczak, Dominika; Eide, Inger Johanne; Gencheva, Radosveta; Lai, Yi; Lewensohn, Rolf; Tsakonas, Georgios; Grundberg, Oscar; de Petris, Luigi; McGowan, Marc Kevin; Brustugun, Odd Terje; Ekman, Simon; Hydbring, Per.
Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer. Translational Lung Cancer Research (TLCR) 2022 ;Volum 11.(5) s. 722-734
VV UiO OUS Untitled
 
3 Kosibaty, Zeinab; Brustugun, Odd Terje; Eide, Inger Johanne Zwicky; Tsakonas, Georgios; Grundberg, Oscar; De Petris, Luigi; McGowan, Marc Kevin; Hydbring, Per; Ekman, Simon.
Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer. Cancers 2022 ;Volum 14.(14) s. -
UiO OUS VV Untitled
 
2017
4 Mcgowan, Marc Kevin; Kleinberg, Lilach; Halvorsen, Ann Rita; Helland, Åslaug; Brustugun, Odd Terje.
NSCLC depend upon YAP expression and nuclear localization after acquiring resistance to EGFR inhibitors. Genes & cancer 2017 ;Volum 8.(3-4) s. 497-504
OUS UiO VV Untitled
 
2016
5 Mcgowan, Marc Kevin; Hoven, Aleksandra Silye; Lund-Iversen, Marius; Solberg, Steinar; Helland, Åslaug; Hirsch, Fred R; Brustugun, Odd Terje.
PIK3CA mutations as prognostic factor in squamous cell lung carcinoma. Lung Cancer 2016 ;Volum 103. s. 52-57
OUS Untitled